BCCM
ETRM

Blue Clay Capital Management’s EnteroMedics Inc. ETRM Stock Holding History

Blue Clay Capital Management’s Portfolio ETRM Stock Details ETRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-198
Closed -$191K – 88
2015
Q1 		$191K Buy
198
+62
+46% +$74.8K 0.1% 70
2014
Q4 		$203K Buy
+136
New +$184K 0.15% 69

Other funds holding ETRM

TCM
Tenor Capital Management New York $6.49B AUM 3.01% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
MAM
MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return
IHM
Iguana Healthcare Management New York $152M AUM 48.74% 1-Year Est. Return
JGC
J. Goldman & Co New York $3.44B AUM 33.8% 1-Year Est. Return
B
Bailard Foster City, California $4.35B AUM 23.57% 1-Year Est. Return

Blue Clay Capital Management's ETRM Position: Q2 2015 in Review

Blue Clay Capital Management sold out of EnteroMedics Inc. (ETRM) in Q2 2015, closing a stake of 198 shares — an estimated $191K sold.

Blue Clay Capital Management first reported a position in ETRM in Q4 2014 and held it in 2 quarters. The position peaked at $203K in Q4 2014. 46 funds tracked by Wall St. Rank hold ETRM as of Q2 2015.

  • Blue Clay Capital Management reported no remaining EnteroMedics Inc. position as of Q2 2015 after selling out during the quarter.
  • Blue Clay Capital Management sold 198 EnteroMedics Inc. shares in Q2 2015, an estimated $191K.
  • Blue Clay Capital Management first reported a position in EnteroMedics Inc. in Q4 2014 and held it in 2 quarters.
  • Blue Clay Capital Management's EnteroMedics Inc. position peaked at $203K in Q4 2014.
  • 46 funds tracked by Wall St. Rank held EnteroMedics Inc. as of Q2 2015.

Based on Blue Clay Capital Management's 13F filing for Q2 2015, filed 14 Aug 2015.